Cardiovascular disease is the world’s top killer, and gut microbes appear to influence coronary artery disease (CAD). Researchers in Seoul found 15 bacterial species tied to CAD, revealing links to inflammation and metabolic imbalance that may worsen the disease. Credit: Shutterstock
New research from Seoul scientists reveals how gut microbes may influence the development of coronary artery disease, the world’s leading killer.
Nearly 20 million people lose their lives each year to cardiovascular diseases, which remain the top cause of death worldwide. While genetics and lifestyle factors influence how these conditions develop and how severe they become, growing evidence suggests that microbes inside the body may also have a powerful impact, especially in coronary artery disease…
Cardiovascular disease is the world’s top killer, and gut microbes appear to influence coronary artery disease (CAD). Researchers in Seoul found 15 bacterial species tied to CAD, revealing links to inflammation and metabolic imbalance that may worsen the disease. Credit: Shutterstock
New research from Seoul scientists reveals how gut microbes may influence the development of coronary artery disease, the world’s leading killer.
Nearly 20 million people lose their lives each year to cardiovascular diseases, which remain the top cause of death worldwide. While genetics and lifestyle factors influence how these conditions develop and how severe they become, growing evidence suggests that microbes inside the body may also have a powerful impact, especially in coronary artery disease (CAD).
Recent research points to the gut microbiome as a key player in how CAD progresses, yet scientists still know little about the exact roles individual bacteria play.
Progress is beginning to accelerate. In a new study published in mSystems, researchers based in Seoul explored how specific gut microbes and their biological functions are linked to CAD.
“We’ve gone beyond identifying ‘which bacteria live there’ to uncovering what they actually do in the heart-gut connection,” said Han-Na Kim, Ph.D., a genomicist at the Samsung Advanced Institute for Health Sciences and Technology at Sungkyunkwan University in Seoul, who led the study.
Mapping the Microbial Landscape
To investigate, Kim’s team analyzed fecal samples from 14 patients diagnosed with CAD and compared them with samples from 28 healthy individuals. They used metagenomic sequencing, a method that examines all the DNA in a sample to reconstruct the genomes of individual microbes.
Through this approach, the researchers identified 15 bacterial species linked to CAD and uncovered several biological pathways that may connect gut microbes to the progression of heart disease.
“Our high-resolution metagenomic map shows a dramatic functional shift toward inflammation and metabolic imbalance, a loss of protective short-chain fatty acid producers, such as Faecalibacterium prausnitzii, and an overactivation of pathways, such as the urea cycle, linked to disease severity,” Kim said.
Notably, the genome-level analysis also suggested that strains of friendly bacteria can turn harmful. Microbes usually categorized as being beneficial to human health, including *Akkermansia muciniphila *and F. prausnitzii, can have different functional roles depending on whether they came from healthy or diseased guts, said Kim.
The Double Nature of Gut Bacteria
The study also revealed the complexity of trying to connect microbes to disease progression. Previous studies have found reduced levels of some species of Lachnospiraceae connected to CAD, for example, but the new study found higher levels of other types. Lachnospiraceae, said Kim, “may be the Dr. Jekyll and Mr. Hyde of the gut.” Some species of the bacteria are depleted in people and others surge in people with CAD. “The big unanswered question now is which strains are the healers, and which are the troublemakers.”
The next step, Kim said, is to integrate these microbial signals with genetic and metabolomic data to more precisely map causal pathways in heart disease. Their larger goal is to design precision-based interventions that can translate microbial information into tools and strategies for preventing cardiovascular disease.
Prevention, Kim said, is the most promising frontier for reducing the global burden of heart disease. Microbial therapies could help—shaping the design of stool-based screening, for example, or through nutritional interventions that restore helpful bacteria or block harmful pathways.
Reference: “Metagenome-assembled genomes reveal microbial signatures and metabolic pathways linked to coronary artery disease” by Soomin Lee, Shahbaz Raza, Eun-Ju Lee, Yoosoo Chang, Seungho Ryu, Hyung-Lae Kim, Si-Hyuck Kang and Han-Na Kim, 6 November 2025, mSystems. DOI: 10.1128/msystems.00954-25
Never miss a breakthrough: Join the SciTechDaily newsletter. Follow us on Google, Discover, and News.